Qualigen
     

 
 
Active pharmaceutical ingredients
Multipurpose units, fully compliant with the GMP's regularly checked by successful internal/external audits.
Class ISO 7 compliance in last synthesis steps and packaging.
 
Critical in-process controls and Cleaning process validation in the whole process to assure the highest quality standards.
 
 
    Active Ingredient   Status
    Bosentan   Under development
    Carvedilol   Regular production
    Ciprofloxacin Base   Regular production
    Desloratadine   Pilot plant
    Dolasetron Mesylate   Pilot plant
    Eletriptan   Under development
    Enalapril Maleate   Regular production
    Fluconazole   Regular production
    Formoterol Fumarate   Regular production
    Granisetron Base / HCL   Regular production
    Irbesartan   Pilot plant
    Lamotrigine   Regular production
    Lisinopril Dihydrate   Regular production
    Loratadine   Regular production
    Montelukast   Pilot plant
    Nedocromil   Regular production
    Nitrendipine   Regular production
    Olanzapine   Pilot plant
    Olmesartan   Pilot plant
    Ondansetron Base / HCL   Regular production
    Palperidone   Under development
    Pioglitazone   Pilot plant
    Quetiapine Hemifumarate   Regular production
    Risperidone   Regular production
    Rizatriptan Benzoate   Pilot plant
    Salmeterol Xinafoate   Regular production
    Telmisartan   Under development
    Terazosin HCL   Regular production
    Voriconazole   Pilot plant
    Ziprasidone   Under development
    Zolmitriptan   Pilot plant
 
 
 
 

Products protected by valid patents are developed with no commercial purposes. These products are under development or study for internal or experimental uses as permitted by the Art. 10.6 of the Directive 2001/83/EC amended by Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004.

None of the products are offered for sale or supplied to countries in which these acts could be in conflict with valid patents.

© All rights reserved. Invent Farma Group.